Enable Biosciences is an award-winning UC Berkeley/Stanford spun-out medical device company where we believe in providing affordable and accessible tests to empower timely diagnosis and treatment of difficult diseases. Based in South San Francisco, Enable leverages its patented ultrasensitive ADAP (Antibody Detection by Agglutination-PCR) technology to detect trace quantities of immunological biomarkers at the earliest treatable stage. Enable has been proudly offering its ADAP assays not only in its 10000 sqft CLIA/research lab but also in renowned institutes worldwide. Excellence of our products and service has been published in numerous peer-reviewed journals. Notably, Enable is proudly working with government entities to provide first-of-its-kind COVID19 testing service to support state-wide monitoring of disease prevalence and vaccination in the California.